Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Balneophototherapy effectively treats ichthyosis linearis circumflexa but may need ongoing treatment due to short remission.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Early recognition of symptoms is crucial for treating IPEX syndrome with a stem cell transplant.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Ixekizumab effectively treats generalized pustular psoriasis.

Patients need better information about the risks of long-term steroid use.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Certain patient traits can predict better hair regrowth with baricitinib in severe alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Some elderly men had healing problems after using imiquimod and diclofenac for skin conditions on their scalps.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

TB can mimic SLE symptoms, so doctors should consider TB in such cases.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Baricitinib improved hair loss and arthritis in a lupus patient.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.